Sodium-glucoser cotransporter 2 inhibitors: glucose lowering against other hypoglycemic agents.

CONCLUSIONS: SGLT-2i are a reliable second line therapy of T2DM, as they can be combined safely with metformin, sulfonylures, incretin mimetics, insulin as well as in triple combinations. In many studies they were prioritised as monotherapy with satisfying effect regarding HbA1c and FPG level reductions. PMID: 29412124 [PubMed - as supplied by publisher]
Source: Cardiovascular and Hematological Disorders Drug Targets - Category: Drugs & Pharmacology Tags: Cardiovasc Hematol Disord Drug Targets Source Type: research